Adipokines and the cardiorespiratory system in young patients with type 1 diabetes mellitus
- Authors: Vengrzhinovskaya O.I.1, Bondarenko I.Z.1, Shatskaya O.A.1, Nikankina l.V.1, Kalashnikov V.Y.1, Shestakova M.V.1, Mokrysheva N.G.1
-
Affiliations:
- National Medical Research Center for Endocrinology
- Issue: Vol 94, No 10 (2022)
- Pages: 1143-1148
- Section: Original articles
- URL: https://journals.rcsi.science/0040-3660/article/view/108271
- DOI: https://doi.org/10.26442/00403660.2022.10.201889
- ID: 108271
Cite item
Full Text
Abstract
Early screening of complications of diabetes mellitus (DM) is one of the priorities for public health. Most patients with type 1 diabetes mellitus (T1DM) are patients of working age. New strategies for the primary prevention of cardiovascular disease (CVD) are needed to prevent their early disability.
Aim. To assess the predictive value of adipokines in relation to a personalized approach to the need for an in-depth examination of young patients with T1DM.
Materials and methods. The study included 98 patients without CVD: 70 patients with T1DM (mean age 26.4±8.1 years) and 28 patients without DM (mean age 27±9 years). All patients underwent a general clinical examination, the levels of adipokines were determined, ergospirometry, echocardiography, and bioimpedancemetry were performed.
Results. Changes in the cardiorespiratory system in patients with T1DM were revealed, in comparison with persons without T1DM: anaerobic threshold was reached faster (p=0.001), maximum oxygen consumption was lower (p=0.048), metabolic equivalent was reduced (p=0.0001). Signs of myocardial remodeling were found in the T1DM group: there was an increase in the relative wall thickness (p=0.001), the posterior wall of the left ventricle (p=0.001), myocardial mass index (p=0.049), in comparison with persons without T1DM. Changes in the adipokines system were revealed: higher levels of resistin (p=0.002) and visfatin (p=0.001), lower level of adiponectin (p=0.040) in T1DM. A positive correlation was found between posterior wall of the left ventricle and visfatin (p=0.014) and a negative relationship between adiponectin and relative wall thickness (p=0.018) in T1DM.
Conclusion. In T1DM, even at a young age, there are multifactorial changes in the heart, which can be detected even at the preclinical stage. The data obtained can be used to identify groups of patients at high risk of developing dangerous CVD in T1DM, which can form the basis for determining the timing of the start of preventive therapy.
Full Text
##article.viewOnOriginalSite##About the authors
Oksana I. Vengrzhinovskaya
National Medical Research Center for Endocrinology
Author for correspondence.
Email: ksuyhap03@mail.ru
ORCID iD: 0000-0003-3370-8630
врач-эндокринолог
Russian Federation, MoscowIrina Z. Bondarenko
National Medical Research Center for Endocrinology
Email: iz_bondarenko@mail.ru
ORCID iD: 0000-0002-5178-6029
д-р мед. наук, врач-кардиолог, гл. науч. сотр.
Russian Federation, MoscowOlga A. Shatskaya
National Medical Research Center for Endocrinology
Email: shatskaya@bk.ru
ORCID iD: 0000-0003-1831-8052
канд. мед. наук, врач-эндокринолог, вед. науч. сотр.
Russian Federation, Moscowlarisa V. Nikankina
National Medical Research Center for Endocrinology
Email: larisa.nikankina@yandex.ru
ORCID iD: 0000-0002-3199-4998
канд. мед. наук, врач клинической лабораторной диагностики, и.о. зав. клинико-диагностической лаб.
Russian Federation, MoscowViktor Y. Kalashnikov
National Medical Research Center for Endocrinology
Email: victor9368@gmail.com
ORCID iD: 0000-0001-5573-0754
чл.-кор. РАН, д-р мед. наук, проф., зав. отд. кардиологии и сосудистой хирургии
Russian Federation, MoscowMarina V. Shestakova
National Medical Research Center for Endocrinology
Email: Shestakova.Marina@endocrincentr.ru
ORCID iD: 0000-0003-3893-9972
акад. РАН, д-р мед. наук, проф., зав. каф. диабетологии и диетологии, дир. Института диабета, зам. дир.
Russian Federation, MoscowNatalia G. Mokrysheva
National Medical Research Center for Endocrinology
Email: mokrisheva.natalia@endocrincentr.ru
ORCID iD: 0000-0002-9717-9742
чл.-кор. РАН, д-р мед. наук, проф., врач-эндокринолог, дир.
Russian Federation, MoscowReferences
- Laukkanen JA, Kurl S, Lakka TA, et al. Exercise-induced silent myocardial ischemia and coronary morbidity and mortality in middle-aged men. J Am Coll Cardiol. 2001;38(1):72-9. doi: 10.1016/s0735-1097(01)01311-0
- Дедов И.И., Шестакова М.В., Викулова О.К. Эпидемиология сахарного диабета в Российской Федерации: клинико-статистический отчет по данным Федерального регистра сахарного диабета. Сахарный диабет. 2017;20(1):13-41 [Dedov II, Shestakova MV, Vikulova OK. Epidemiology of diabetes mellitus in Russian Federation: clinical and statistical report according to the federal diabetes registry. Diabetes Mellitus. 2017;20(1):13-41 (in Russian)]. doi: 10.14341/DM8664
- Balady GJ, Arena R, Sietsema K, et al; American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee of the Council on Clinical Cardiology; Council on Epidemiology and Prevention; Council on Peripheral Vascular Disease; Interdisciplinary Council on Quality of Care and Outcomes Research. Clinician's Guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association. Circulation. 2010;122(2):191-225. doi: 10.1161/CIR.0b013e3181e52e69
- Всероссийское научное общество кардиологов. Прогнозирование и профилактика кардиальных осложнений внесердечных хирургических вмешательств. Национальные клинические рекомендации. Кардиоваскулярная терапия и профилактика. 2011;10(6, приложение 3):1-28 [Russian Scientific Society of Cardiologists. Prediction and Prevention of Cardiac Complications of Noncardiac Surgical Interventions. National Clinical Guidelines. Kardiovaskulyarnaya terapiya i profilaktika. 2011;10(6, prilozhenie 3):1-28 (in Russian)].
- Rudski LG, Lai WW, Afilalo J, еt al. Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A Report from the American Society of Echocardiography Endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2010;23(7):685-713. doi: 10.1016/j.echo.2010.05.010
- Парфенова Н.С., Танянский Д.А. Адипонектин: благоприятное воздействие на метаболические и сердечно-сосудистые нарушения. Артериальная гипертензия. 2013;19(1):84-96 [Parfenovа NS, Tanyanskiy DA. Adiponectin: beneficial effects on metabolic and cardiovascular dysfunctions. Arterialnaya Gipertenziya (Arterial Hypertension). 2013;19(1):84-96 (in Russian)]. doi: 10.18705/1607-419X-2013-19-1-84-96
- Вавилова Т.П., Плетень А.П., Михеев Р.К. Биологическая роль адипокинов как маркеров патологических состояний. Вопросы питания. 2017;86(2):5-13 [Vavilova TP, Pleten' AP, Mikheev RK. Biological role of adipokines and their association with morbid conditions. Voprosy pitaniia. 2017;86(2):5-13 (in Russian)]. doi: 10.1073/pnas.1920004117
- Bailey SD, Loredo-Osti JC, Lepage P, et al. Common polymorphisms in the promoter of the visfatin gene (PBEF1) influence plasma insulin levels in a French-Canadian population. Diabetes. 2006;55(10):2896-902. doi: 10.2337/db06-0189
- Гайворонский И.В., Ничипорук Г.И., Гайворонский И.Н., Ничипорук Н.Г. Биоимпедансометрия как метод оценки компонентного состава тела человека (обзор литературы) Вестник СПбГУ. Медицина. 2017;12(4):365-84 [Gaivoronsky IV, Nichiporuk GI, Gaivoronsky IN, Nichiporuk NG. Bioimpedansometry As A Method For Assessing The Component Composition Of The Human Body (Literature Review). Vestnik of Saint Petersburg University. Medicine. 2017;12(4):365-84 (in Russian)]. doi: 10.21638/11701/spbu11.2017.406
- Cho YH, Craig ME, Davis EA, et al; Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial. Cardiac autonomic dysfunction is associated with high-risk albumin-to-creatinine ratio in young adolescents with type 1 diabetes in AdDIT (adolescent type 1 diabetes cardio-renal interventional trial). Diabetes Care. 2015;38(4):676-81. doi: 10.2337/dc14-1848
- Barstow TJ, Molé PA. Linear and nonlinear characteristics of oxygen uptake kinetics during heavy exercise. J Appl Physiol (1985). 1991;71(6):2099-106. doi: 10.1152/jappl.1991.71.6.2099
- Agostoni P, Cattadori G, Bussotti M, Apostolo A. Cardiopulmonary interaction in heart failure. Pulm Pharmacol Ther. 2007;20(2)130-4. doi: 10.1016/j.pupt.2006.03.001
- Alway SE, Mohamed JS, Myers MJ. Mitochondria Initiate and Regulate Sarcopenia. Exerc Sport Sci Rev. 2017;45(2):58-69. doi: 10.1249/JES.0000000000000101
- Муха Н.В., Говорин А.В., Зайцев Д.Н., Филев А.П. Структурно-функциональные нарушения миокарда и аритмии у больных сахарным диабетом 1 типа, осложненным кетоацидозом. Российский кардиологический журнал. 2020;25(7):3891 [Mukha NV, Govorin AV, Zaitsev DN, Filev AP. Structural and functional myocardial disorders and arrhythmias in patients with type 1 diabetes mellitus complicated by ketoacidosis. Russian Journal of Cardiology. 2020;25(7):3891. (in Russian)]. doi: 10.15829/1560-4071-2020-3891
- Acar G, Akcay A, Sokmen A, et al. Assessment of atrial electromechanical delay, diastolic functions, and left atrial mechanical functions in patients with type 1 diabetes mellitus. J Am Soc Echocardiogr. 2009;22(6):732-8. doi: 10.1016/j.echo.2009.03.028
- Цветкова М.В., Хирманов В.Н., Зыбина Н.Н. Роль неэтерифицированных жирных кислот в патогенезе сердечно-сосудистых заболеваний. Артериальная гипертензия. 2010;16(1):93-103 [Tsvetkova MV, Khirmanov VN, Zybina NN. The role of nonesterified fatty acids in pathogenesis of cardiovascular disease. Arterial Hypertension. 2010;16(1):93-103 (in Russian)]. doi: 10.18705/1607-419X-2010-16-1-93-103
- Bando YK, Murohara T. Diabetes-related heart failure. Circ J. 2014;78(3):576-83. doi: 10.1253/circj.cj-13-1564
- Ouchi N, Ohishi M, Kihara S, et al. Fssociation of hypoadiponectinemia with impaired vasoreactivity. Hypertension. 2003;42:231-4. doi: 10.1161/01.hyp.0000083488.67550.b8
- Iwashima Y, Katsuya T, Ishikawa K, et al. Hypoadiponectinemia is an Independent Risk Factor for Hypertension. Hypertension. 2004;43:1318-23. doi: 10.1161/01.hyp.0000129281.03801.4b
- Вербовой А.Ф., Цанава И.А., Вербовая Н.И. Адипокины и метаболические показатели у больных сахарным диабетом 2 типа в сочетании с подагрой. Ожирение и метаболизм. 2016;13(1):20-4 [Verbovoy AF, Tsanava IA, Verbovaya NI. Adipokines and metabolie patients with type 2 diabetes mellitus in combination with gout. Ozhirenie i metabolism. 2016;13(1):20-4 (in Russian)]. doi: 10.14341/omet2016120-24
- Schnabel R, Messow CM, Lubos E, et al. Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study. Eur Heart J. 2008;29(5):649-57. doi: 10.1093/eurheartj/ehn009
- Calabro P, Samudio I, Willerson JT, Yeh ET. Resistin Promotes Smooth Muscle Cell Proliferation Through Activation of Extracellular Signal-Regulated Kinase 1/2 and Phosphatidylinositol 3-Kinase Pathways. Circulation. 2004;110(21):3335-40. doi: 10.1161/01.CIR.0000147825.97879.E7
- Теряева Н.Б. Адипокины: регуляция энергетического метаболизма и патогенез сердечно-сосудистых заболеваний. Креативная кардиология. 2007;1-2:20-5 [Teryaeva NB. Adiponectin: regulation of energymetabolism and the pathogenesis of cardiovascular diseases. Creative Cardiology. 2007;12:20-5 (in Russian)].
- Frankel DS, Vasan RS, D'Agostino RB, et al. Resistin, Adiponectin, and Risk of Heart Failure. J Am Coll Cardiol. 2009;53(9):754-62. doi: 10.1016/j.jacc.2008.07.073
Supplementary files
![](/img/style/loading.gif)